Verona Pharma Community
NasdaqGM:VRNA Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 17 Fair Values set on narratives written by author
Community Investing Ideas
AN
Consensus Narrative from 10 Analysts
Ohtuvayre Launch And EU Approval Will Unlock Future Markets
Key Takeaways Rapid adoption of Ohtuvayre for COPD and strong prescription growth suggest significant future revenue potential. Global regulatory advancements and strategic financing bolster potential for new revenue streams and acquisitions.
View narrativeUS$94.10
FV
24.2% undervalued intrinsic discount112.36%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
7 days ago author updated this narrative